WE SEE THE FUTURE FIRST

WE SEE THE FUTURE FIRST

Minerva Biotechnologies is focused on cancer and stem cell therapeutics. We are developing cancer immunotherapies targeting 80% of solid tumors and to prevent cancer metastasis

more info
patternframe

Welcome to Minerva Biotechnologies

Exploring the Space between Cancers and Stem Cells

Cancer Therapeutics

Cancer Therapeutics

Minerva's CAR T therapeutics will attack solid tumors that are MUC1* positive. This represents approximately 80% of all cancers.

learn more
Regenerative Medicine

Regenerative Medicine

Minerva’s stem cell discoveries will enable pharmaceutical companies to utilize regenerative medicine in a variety of diseases.

learn more
AlphaSTEM®

AlphaSTEM®

Using AlphaSTEM® iPSC generation is more efficient, cell expansion is faster, and differentiation efficiency is increased.

learn more

We See The Future First.

Job

Latest News

July 9, 2018

Cancer Cell Scientist

Cancer Cell Scientist Minerva Biotechnologies has immediate openings for its

May 2, 2018

Dr. Cynthia Bamdad Presents at ISCT Montreal. Room 519AB, Thursday, May 3, 2018 at 11:00 AM.

Dr. Cynthia Bamdad, CEO of Minerva Biotechnologies, will present a talk entitled,

April 3, 2018

Minerva Biotechnologies Presenting at the American Association for Cancer Research (AACR) Conference

Dr. Cynthia Bamdad, CEO of Minerva Biotechnologies, will present a poster entitled,

View All News

We See The Future First.

Sign Up For Our Mailing List.